DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 51 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2016$3,170,000
-68.6%
1,315,5510.0%0.14%
-67.0%
Q4 2015$10,090,000
+45.0%
1,315,5510.0%0.41%
+52.0%
Q3 2015$6,959,000
-41.0%
1,315,5510.0%0.27%
-31.6%
Q2 2015$11,800,000
+36.8%
1,315,551
-3.6%
0.39%
+40.9%
Q1 2015$8,627,000
+239.0%
1,365,000
+458.2%
0.28%
+168.3%
Q1 2014$2,545,000244,5240.10%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2015
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,547,248$3,729,0000.20%
Broadfin Capital, LLC 825,986$1,991,0000.19%
PURA VIDA INVESTMENTS, LLC 159,877$385,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,315,551$3,170,0000.14%
FT Options LLC 50,600$122,0000.13%
Lombard Odier Asset Management (USA) Corp 231,974$559,0000.08%
SABBY MANAGEMENT, LLC 385,248$928,0000.05%
Integre Asset Management, LLC 57,501$139,0000.04%
BLUESTEIN R H & CO LLC 185,975$448,0000.03%
Alambic Investment Management, L.P. 33,880$82,0000.03%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders